MARKET

XBI

XBI

State Street® SPDR® S&P® Biotech ETF
NYSEARCA
154.43
-0.08
-0.05%
After Hours: 154.52 +0.09 +0.06% 19:41 10/02 EDT
OPEN
156.41
PREV CLOSE
154.51
HIGH
156.74
LOW
153.58
VOLUME
8.75M
TURNOVER
--
52 WEEK HIGH
169.89
52 WEEK LOW
97.59
TOTAL ASSET
10.09B
YTD YIELD
51.13%
1D
5D
1M
3M
1Y
5Y
1D
Notable ETF Outflow Detected - XBI, TWST, BIIB, HALO
NASDAQ · 1d ago
Where Healthcare Innovation Meets Investment Opportunity
Seeking Alpha · 2d ago
'HHS launches project to speed up clinical trials' - Axios
Benzinga · 3d ago
Nasdaq 100 Climbs as Cooler PCE Cuts Rate Hike Bets, Micron Earnings Loom: Stock Market Today
Benzinga · 3d ago
Moderna slips as Citi cuts to Sell on “unjustifiable” valuation
Seeking Alpha · 4d ago
New Grades, Price Targets for the Top-3 Stocks in the Market’s Hottest Sector
TipRanks · 4d ago
Is State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?
NASDAQ · 5d ago
Weekly Report: what happened at XBI last week (0921-0925)?
Weekly Report · 6d ago
More
Profile
Fund Name
State Street® SPDR® S&P® Biotech ETF
Inception Date
2006-01-31
Benchmark
S&P 500 (TR) (1970)
Advisor Company
SPDR State Street Investment Management
Custodian
State Street Bank & Trust Co
Manager
Michael Feehily, Emiliano Rabinovich, Raymond Donofrio, Karl Schneider